New mechanism discovered: B cells’ contribution to immune tolerance in thymus gland

Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a previously unknown mechanism behind this: other immune cells, the B cells, contribute to the “training” of the T cells in the thymus gland.

Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

Broken String Biosciences enhances its leadership team with Laurence Reid and Brad Crutchfield, aiming to revolutionize cell and gene therapy development.

September 23, 2024

Novo Nordisk to buy PhIII kidney disease drug from Singapore’s KBP Biosciences

Novo Nordisk will pay up to $1.3 billion to buy a small molecule currently in Phase III for uncontrolled hypertension and advanced chronic kidney disease

October 17, 2023

Navigator secures $100m to develop antibody therapeutics

NAV-240 is undergoing Phase I development, focusing on complex autoimmune diseases. Credit: Panchenko Vladimir/Shutterstock. Navigator Medicines has secured $100m in a Series A financing round

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.